Promotions

20% Off COVID-19 Diagnosis Related Reagents

Time:2020-03-02 16:19:41 View:


It is distressful that the 2019 novel coronavirus (2019-nCoV) is spreading across the world.Confirmed cases of Coronavirus disease 2019 (COVID-19) now span close to 50 countries and 2019-nCoV has afflicted more than 80,000 people. Accurate RNA detection of 2019-nCoV is strongly recommended for differential diagnosis by global health care authorities. The RNA is detected by Real-Time RT-PCR, a molecular in vitro diagnostic test that is based on widely used nucleic acid amplification technology.                                                                      

20% Off COVID-19 Diagnosis Related Reagents

TransGen Biotech provides core materials for qRT-PCR diagnosis and offer 20% discount for all related reagents to support combating COVID-19 globally.


Sufficient inventory & high output & quick delivery (1-2 weeks) for COVID-19 related reagents


Viral nucleic acid extraction reagents based on spin column or magnetic beads

EasyPure® Viral DNA/RNA Kit (ER201)

MagicPure® Viral DNA/RNA Kit (EC301)


One-step probe qRT-PCR reagents with high specificity, high sensitivity and high efficiency

TransScript® II Probe One-Step qRT-PCR SuperMix (AQ321)

TransScript® Probe One-Step qRT-PCR SuperMix (AQ221)




20% discount is applied to all nucleic acid extraction and qPCR & qRT-PCR reagents


Terms & Conditions

1. Promotion is only valid from March 1st to April 30th.

2. 20% discount is only valid for end users while distributors enjoy 10% additional discount based on original transfer price.

3.  Promotion is applied to the international market, excluding P.R. China.

4.  TransGen Biotech reserves the right to amend privileges, terms and conditions without prior notice.

 

References

[1] Jin Y H, Cai L, Cheng Z S, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)[J]. Military Medical Research, 2020, 7(1): 4.

[2] Shen K, Yang Y, Wang T, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement[J]. World Journal of Pediatrics, 2020: 1-9.

[3] Wang F S, Zhang C. What to do next to control the 2019-nCoV epidemic?[J]. The Lancet, 2020, 395(10222): 391-393.

[4] CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel. CDC/DDID/NCIRD/ Division of Viral Diseases, CDC-006-00019, Revision: 01.

 


Message